Arizona professor receives 2013 Rosalynn Carter Leadership in Caregiving Award Is National Caregivers Month November, a time to acknowledge the important function family and friends play in looking after their ailing and elderly family members /intimate-life.html . Aptly timed, the Rosalynn Carter Institute for Caregiving named David W recently. Coon, PhD, associate vice professor and provost in the College of Nursing & Health Creativity at Arizona State University, and his fellow experts the 2013 Rosalynn Carter Leadership in Caregiving Award.
ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating type of human EPO Human being erythropoietin is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord damage, and Parkinson’s disease. Nevertheless, EPO drug development for the brain is bound, because EPO does not cross the blood-brain barrier . In acute brain or stroke injury, the BBB is usually intact in the first hours after the insult when neuroprotection continues to be possible. Therefore, large molecule biopharmaceuticals such as for example EPO must be re-manufactured to enable BBB transport. ArmaGen Technologies is rolling out the BBB molecular Trojan equine system technology for solving the BBB drug delivery issue, and has used this technology to make a brain penetrating form of human being EPO.